GURUFOCUS.COM » STOCK LIST » Creative Antibiotics AB (OSTO:CAS) » Definitions » Cash Flow from Investing

Creative Antibiotics AB (OSTO:CAS) Cash Flow from Investing : kr0.00 Mil (TTM As of Mar. 2013)


View and export this data going back to . Start your Free Trial

What is Creative Antibiotics AB Cash Flow from Investing?

Cash Flow from Investing covers the cash a company gains or spends from investment activities in financial market and operating subsidiaries. It also includes the cash the company used for property, plant and equipment (PPE).

For the three months ended in Mar. 2013, Creative Antibiotics AB spent kr0.00 Mil on purchasing property, plant, equipment. It gained kr0.00 Mil from selling property, plant, and equipment. It spent kr0.00 Mil on purchasing business. It gained kr0.00 Mil from selling business. It spent kr0.00 Mil on purchasing investments. It gained kr0.00 Mil from selling investments. It paid kr0.00Mil for net Intangibles purchase and sale. And it paid kr0.00 Mil for other investing activities. In all, Creative Antibiotics AB gained kr0.00 Mil on investment activities in financial market and operating subsidiaries for the three months ended in Mar. 2013.


Creative Antibiotics AB Cash Flow from Investing Historical Data

The historical data trend for Creative Antibiotics AB's Cash Flow from Investing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Creative Antibiotics AB Cash Flow from Investing Chart

Creative Antibiotics AB Annual Data
Trend Jun08 Jun09 Jun10 Dec11
Cash Flow from Investing
-0.22 -0.51 - -

Creative Antibiotics AB Quarterly Data
Jun08 Mar09 Jun09 Sep09 Dec09 Mar10 Sep10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Mar13
Cash Flow from Investing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Creative Antibiotics AB Cash Flow from Investing Calculation

Cash Flow from Investing covers the cash a company gains or spends from investment activities in financial market and operating subsidiaries. It also includes the cash the company used for property, plant and equipment (PPE).

If a company spends cash on property, plant and equipment (PPE), this will reduce their cash position. This is called Capital Expenditures (CPEX).

Likewise, if a company buys another company for cash, this will reduce their cash position.

Creative Antibiotics AB's Cash Flow from Investing for the fiscal year that ended in Dec. 2011 is calculated as:

Creative Antibiotics AB's Cash Flow from Investing for the quarter that ended in Mar. 2013 is calculated as:


Cash Flow from Investing for the trailing twelve months (TTM) ended in Mar. 2013 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Creative Antibiotics AB  (OSTO:CAS) Cash Flow from Investing Explanation

Cash flow from investing contains nine items:

1. Purchase Of Property, Plant, Equipment:
Purchase of PPE indicates the amount used to purchase property, plant, and equipment.

Creative Antibiotics AB's purchase of property, plant, equipment for the three months ended in Mar. 2013 was kr0.00 Mil. It means Creative Antibiotics AB spent kr0.00 Mil on purchasing property, plant, equipment.

In the capital spending for property, plant and equipment (PPE), some part of spending may be from the expansion of business. The business needs more property, plant and equipment (PPE) as it grows. Another part may be from replacement of the property, plant and equipment (PPE) of existing business. For some companies, the cash spent on replacing of the property, plant and equipment (PPE) of the existing business will be close to the depreciation of property, plant and equipment (PPE) reported in the income statement.

In Warren Buffett's definition of Owner's Earnings, he deducts the estimate of the cost of replacing the property, plant and equipment (PPE) of the existing business from cash flow from operations. The cash spent on the new property, plant, and equipment is not deducted. The reason is because these are not costs of the existing business. In his 1986 letter to shareholders, Warren Buffett wrote this about owner earnings:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume....Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

2. Sale Of Property, Plant, Equipment:
Sale of PPE indicates the amount gained from selling property, plant, and equipment.

Creative Antibiotics AB's sale of property, plant, equipment for the three months ended in Mar. 2013 was kr0.00 Mil. It means Creative Antibiotics AB gained kr0.00 Mil from selling property, plant, and equipment.

3.Purchase Of Business:
Purchase of business indicates the amount used to purchase business.

Creative Antibiotics AB's purchase of business for the three months ended in Mar. 2013 was kr0.00 Mil. It means Creative Antibiotics AB spent kr0.00 Mil on purchasing business.

4. Sale Of Business:
Sale of business indicates the amount gained from selling business.

Creative Antibiotics AB's sale of business for the three months ended in Mar. 2013 was kr0.00 Mil. It means Creative Antibiotics AB gained kr0.00 Mil from selling business.

5. Purchase Of Investment:
Purchase of Investments represents cash outflow on the purchase of investments in securities.

Creative Antibiotics AB's purchase of investment for the three months ended in Mar. 2013 was kr0.00 Mil. It means Creative Antibiotics AB spent {stock_data.stock.currency_symbol}}0.00 Mil on purchasing investments.

6. Sale Of Investment:
Sale of Investments represents cash inflow on the sale of investments in securities.

Creative Antibiotics AB's sale of investment for the three months ended in Mar. 2013 was kr0.00 Mil. It means Creative Antibiotics AB gained kr0.00 Mil from selling investments.

7. Net Intangibles Purchase And Sale:
Net Intangibles purchase and sale means the net cash inflow received by a company that comes from the purchase and sale of intangibles. It equals the cash received from sale of intangibles minus the cash spent on purchasing intangibles.

Creative Antibiotics AB's net Intangibles purchase and sale for the three months ended in Mar. 2013 was kr0.00 Mil. It means Creative Antibiotics AB paid kr0.00 Mil for net Intangibles purchase and sale.

8. Cash From Discontinued Investing Activities:
Cash from discontinued investing activities means the cash received by a company that comes from the discontinued investing activities.

Creative Antibiotics AB's cash from discontinued investing activities for the three months ended in Mar. 2013 was 0.00 Mil. It means Creative Antibiotics AB paid kr0.00 Mil for discontinued investing activities.

9. Cash From Other Investing Activities:
Cash from other investing activities means the cash received by a company that comes from other investing activities.

Creative Antibiotics AB's cash from other investing activities for the three months ended in Mar. 2013 was kr0.00 Mil. It means Creative Antibiotics AB paid kr0.00 Mil for other investing activities.


Creative Antibiotics AB Cash Flow from Investing Related Terms

Thank you for viewing the detailed overview of Creative Antibiotics AB's Cash Flow from Investing provided by GuruFocus.com. Please click on the following links to see related term pages.


Creative Antibiotics AB (OSTO:CAS) Business Description

Traded in Other Exchanges
N/A
Address
Website

Creative Antibiotics AB (OSTO:CAS) Headlines

From GuruFocus

Cascade Acquisition Corp (CAS.U) CEO Jay N. Levine Bought $2.5 million of Shares

By GuruFocus Research GuruFocus Editor 11-27-2020

Cascade Acquisition Corp. Announces Liquidation

By GuruFocusNews GuruFocusNews 07-07-2022

Cascade Acquisition Corp. Announces Liquidation

By GuruFocusNews GuruFocusNews 06-27-2022

Cascade Acquisition Corp. Announces Liquidation

By GuruFocusNews GuruFocusNews 05-18-2022

Cascade Acquisition Corp. Announces Liquidation

By GuruFocusNews GuruFocusNews 06-07-2022

Cascade Acquisition Corp. Announces Liquidation

By GlobeNewswire GlobeNewswire 05-18-2022

Cascade Acquisition Corp. Announces Liquidation

By GuruFocusNews GuruFocusNews 05-28-2022